Showing results (1491-1500 of 1,528) with videos related to
Sort By:
Pageof 153
Acta Neurochirurgica|November 11, 2024
Treatment of adult spine deformity: A retrospective comparison of bone morphogenic protein and bone marrow aspirate with bone allograftOluwatobi O Onafowokan, Akachimere C Uzosike, Abhinav Sharma, et al.The New England Journal of Medicine|July 2, 1981
Treatment of primary breast cancer with chemotherapy and tamoxifenB Fisher, C Redmond, A Brown, et al.Physical Review Letters|December 10, 2021
Role of Equilibrium Fluctuations in Light-Induced OrderAlfred Zong, Pavel E Dolgirev, Anshul Kogar, et al.Diabetes|November 10, 2020
Pancreatic β-Cell-Specific Deletion of VPS41 Causes Diabetes Due to Defects in Insulin SecretionChristian H Burns, Belinda Yau, Anjelica Rodriguez, et al.Spine|December 17, 2024
Single-Position Prone Lateral Interbody Fusion is Associated with Improved Radiographic and Clinical Outcomes at One Year compared to Single-Position Lateral Interbody Fusion: A Single Institution ExperienceAnthony Yung, Oluwatobi O Onafowokan, Peter S Tretiakov, et al.Blood|November 22, 2017
CD38-bispecific antibody pretargeted radioimmunotherapy for multiple myeloma and other B-cell malignanciesDamian J Green, Shyril O'Steen, Yukang Lin, et al.CBE Life Sciences Education|May 24, 2019
Recommendations for Effective Integration of Ethics and Responsible Conduct of Research (E/RCR) Education into Course-Based Undergraduate Research Experiences: A Meeting ReportLaura A Diaz-Martinez, Ginger R Fisher, David Esparza, et al.Journal of the National Cancer Institute|November 6, 1996
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumorsB Fisher, J Dignam, J Bryant, et al.Cancer Research|September 4, 2016
Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell CancersDamian J Green, Shani L Frayo, Yukang Lin, et al.Cancer Research|December 28, 2013
A preclinical model of CD38-pretargeted radioimmunotherapy for plasma cell malignanciesDamian J Green, Nural N Orgun, Jon C Jones, et al.Pageof 153